These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9876820)

  • 1. Botulinum toxin type A injection for the treatment of frown lines.
    Song KH
    Ann Pharmacother; 1998 Dec; 32(12):1365-7. PubMed ID: 9876820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique.
    Lowe NJ; Maxwell A; Harper H
    J Am Acad Dermatol; 1996 Oct; 35(4):569-72. PubMed ID: 8859286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE; Easthope SE
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A; Carruthers J
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines.
    Stengel G; Bee EK
    Clin Interv Aging; 2011; 6():281-4. PubMed ID: 22162643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study.
    Prager W; Bee EK; Havermann I; Zschocke I
    Clin Interv Aging; 2013; 8():449-56. PubMed ID: 23650444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for the correction of hyperkinetic facial lines.
    Goodman G
    Australas J Dermatol; 1998 Aug; 39(3):158-63. PubMed ID: 9737041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
    Dolar Bilge A; Sadigov F; Salar-Gomceli S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study.
    Lee DH; Kang SM; Feneran A; Youn CS; Kim JK; Cho S; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e1-7. PubMed ID: 23030660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
    Carruthers A; Carruthers J; Coleman WP; Donofrio L; Flynn T; Gold M; Heinz M; Harrington L; Jones D; McDaniel D; Rohrer T; Schlöbe A; Solish N; Weiss RA
    Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
    Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
    Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
    Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
    Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.